Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.
D012369:2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- / Q000494:pharmacology; D015102:3,4-Dihydroxyphenylacetic Acid / Q000096:biosynthesis* / Q000302:isolation & purification; D000818:Animals; D002396:Catechols / Q000302:isolation & purification; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism*; D003042:Cocaine / Q000494:pharmacology; D004298:Dopamine / Q000302:isolation & purification / Q000378:metabolism*; D004347:Drug Interactions; D066298:In Vitro Techniques; D008297:Male; D008745:Methylation; D010648:Phenylacetates / Q000096:biosynthesis*; D011339:Probenecid / Q000494:pharmacology; D011699:Putamen / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D013569:Synapses / Q000378:metabolism
D002396:Catechols; D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D012369:2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; D003042:Cocaine; D011339:Probenecid; D004298:Dopamine